Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) EBT Margin (2017 - 2025)

Creative Medical Technology Holdings has reported EBT Margin over the past 9 years, most recently at 62922.47% for Q4 2025.

  • Quarterly EBT Margin fell 112000.0% to 62922.47% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 99916.8% through Dec 2025, down 4997606.0% year-over-year, with the annual reading at 99916.8% for FY2025, 4997606.0% down from the prior year.
  • EBT Margin was 62922.47% for Q4 2025 at Creative Medical Technology Holdings, down from 54603.23% in the prior quarter.
  • Over five years, EBT Margin peaked at 1786.07% in Q3 2022 and troughed at 62922.47% in Q4 2025.
  • The 5-year median for EBT Margin is 26642.18% (2021), against an average of 31257.95%.
  • Biggest five-year swings in EBT Margin: soared 21496579bps in 2021 and later plummeted -2769778bps in 2022.
  • Tracing CELZ's EBT Margin over 5 years: stood at 5719.92% in 2021, then tumbled by -484bps to 33417.7% in 2022, then plummeted by -67bps to 55952.47% in 2023, then fell by -10bps to 61802.47% in 2024, then decreased by -2bps to 62922.47% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 62922.47%, 54603.23%, and 61802.47% for Q4 2025, Q1 2025, and Q4 2024 respectively.